Table 3.
EGFR interface | Crystal structure used | Distance between ligands* (Å) | Effect of addition of dye to distance† | Surface area (Å2)‡ | ΔG§ (kcal/mol) (p-value) |
---|---|---|---|---|---|
Back-to-back | 1mox (12) | 111 | Increase | 1107 | −17.3 (0.043) |
Head-to-head | 1mox (12) | 50 | Decrease (min 27 Å) | 440 | −3.1 (0.430) |
Back-to-back | 1ivo (13) | 111 | Increase | 1315 | −14.0 (0.132) |
Weak A:A | 1ivo (13) | 64 | Increase | 455 | 0.3 (0.559) |
Weak B:B | 1ivo (13) | 46 | Decrease | 284 | 1.0 (0.749) |
Head-to-back§ | 1nql (15) | 53 | Similar | 956 | −9.9 (0.263) |
Domain II/IV interactions¶ | 1nql (15) | 68 | Similar | 655 | −5.7 (0.366) |
Perpendicular | 1yy9 (73) | 816 | −5.0 (0.417) | ||
HER3 conformation‖ | 1m6b (64) | 1877 | −21.0 (0.061) |
Distances between EGF or TGFα molecules are from the first determined amino acid residues (residues 2/3 in 1mox and residue 5 in 1ivo).
Size of Cy3 or Cy5 dye used is ∼20 Å.
Calculated by PISA (53).
ΔG is the solvation free energy gain upon formation of the interface, as calculated by PISA. It does not include the effect of satisfied hydrogen bonds and salt bridges across the interface. The p-value is the probability of getting a lower than obtained ΔG, if interface atoms are picked randomly from the protein surface.
Inactive crystallographic dimer.
Crystal of unliganded HER3 dimer.